Japan
Takeda's 2026 Sustainability Performance: Climate Progress, Pharmaceutical Responsibility and the Challenge of Value Chain Decarbonisation
Takeda’s 2026 sustainability disclosures reveal progress in climate action, ESG governance, patient access and responsible pharmaceutical manufacturing. This analysis examines its emissions performance, supply chain challenges, social responsibility and independent assurance.